Metabolic Plasticity in Melanoma Progression and Response to Oncogene Targeted Therapies
Resistance to therapy continues to be a barrier to curative treatments in melanoma. Recent insights from the clinic and experimental settings have highlighted a range of non-genetic adaptive mechanisms that contribute to therapy resistance and disease relapse, including transcriptional, post-transcr...
Guardado en:
Autores principales: | Arwa Alkaraki, Grant A. McArthur, Karen E. Sheppard, Lorey K. Smith |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1ac67eaffb2a49feb0dabf881ea79789 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
RAC1 Activation as a Potential Therapeutic Option in Metastatic Cutaneous Melanoma
por: Paula Colón-Bolea, et al.
Publicado: (2021) -
Late diagnosis of nodular melanoma of the foot in a 74-year-old Brazilian man
por: Santos,Vitorino M, et al.
Publicado: (2011) -
Melanoma metastásico con tumor primario oculto
por: Bórquez M,Pablo, et al.
Publicado: (2012) -
Reporte de dos casos clínicos de melanoma con metástasis cardíacas: ("Dos caras de una misma moneda")
por: Cabrera,Ignacio, et al.
Publicado: (2016) -
Individualized Treatment Strategy for Cutaneous Melanoma: Where Are We Now and Where Are We Going?
por: Huihua Zeng, et al.
Publicado: (2021)